Hydrocortisone
FDA-approved product (tablet, oral), marketed as Acticort, Aeroseb-Hc, Ala-Cort and 34 more.
- Registered studies
- 50+
- Lab records
- 0
- Pathogens at ≥40%
- 1 of 4
Chemical structure
Existing / approved use
Documented · FDA, WHO, ChEMBLApproved for
- Adrenal gland disease
- Adrenocortical insufficiency
- Allergic conjunctivitis
- Asthma
- Atopic eczema
- Bursitis
- Cancer
- Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency
- Congenital adrenal hyperplasia
- Crohn's disease
- Dermatitis
- Endocrine system disease
- Exanthem
- Eye inflammation
- Hemorrhoid
- Herpes Labialis
- and 19 more
Indications ChEMBL records as approved, from FDA and DailyMed labels. Label ↗
- WHO therapeutic group
- Corticosteroids for local oral treatment; Corticosteroids acting locally; Corticosteroids; Corticosteroids, weak (group i); Corticosteroids, weak, other combinations
- FDA pharmacologic class
- Corticosteroid FDA label ↗
- Anti-infective classification
- Not classified as an anti-infective.
Repurposing investigation
This medicine is being investigated here for AI-predicted antimicrobial activity against MRSA. It was surfaced computationally for further investigation; it is not an established treatment for this infection.
AI-predicted activity
AI prediction · nothing measured- MRSA50.5% AI-predicted activityAt or above the ≥40% mark this site uses to surface candidates.
- E. coli24.7% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
- K. pneumoniae22.1% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
- M. tuberculosis31.1% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
A model’s estimate of laboratory activity against each pathogen species. It is not clinical effectiveness.
Evidence
Clinical and experimental
Documented evidenceClinical
50+registered studies name this medicine, for any condition. The registry search keeps the first 50, so there may be more. See them below.
Experimental
No evidence found
No laboratory measurement against the four pathogens in the ChEMBL records loaded here.
Docking
Computational · nothing measuredAutoDock Vina, one experimentally solved protein per pathogen. This project’s screening target is -7.0 kcal/mol, its own mark rather than a universal cutoff. A docking score is a structural hypothesis, not proof of binding, and requires experimental validation.
Other medicines to investigate
AI prediction · nothing measuredOther repurposing candidates: approved medicines besides Hydrocortisone with AI-predicted activity ≥40% against the chosen pathogen, leaving out existing antimicrobials. They are computational candidates for further investigation, not alternatives and not recommendations.
Sorted by AI-predicted activity, high to low. The order is not a ranking of which medicine is better.
- Ozanimod HydrochlorideExisting use: Multiple sclerosis, Relapsing-remitting multiple sclerosis, Ulcerative colitis66.8% AI-predicted activityagainst MRSA7 registered studies
- Micafungin SodiumExisting use: Candidiasis66.8% AI-predicted activityagainst MRSA50+ registered studies
- AbemaciclibExisting use: Breast cancer, Breast carcinoma, Breast neoplasm and 3 more66.4% AI-predicted activityagainst MRSA50+ registered studies
- RisperidoneExisting use: Aggressive behavior, Autism, Bipolar disorder and 4 more66.4% AI-predicted activityagainst MRSA50+ registered studies
- Lazertinib MesylateExisting use: Non-small cell lung carcinoma66.1% AI-predicted activityagainst MRSANo documented evidence found
- Desmopressin AcetateExisting use: Central diabetes insipidus, Diabetes insipidus, Enuresis and 5 more65.8% AI-predicted activityagainst MRSA50+ registered studies
- Terazosin HydrochlorideExisting use: Benign prostatic hyperplasia65.8% AI-predicted activityagainst MRSA41 registered studies
- VemurafenibExisting use: Cancer, Cutaneous melanoma, Melanoma and 2 more65.8% AI-predicted activityagainst MRSA50+ registered studies
- Caspofungin AcetateExisting use: Aspergillosis, Candidemia, Candidiasis and 1 more65.5% AI-predicted activityagainst MRSA50+ registered studies
- VenetoclaxExisting use: Cancer, Chronic lymphocytic leukemia, Neoplasm65.5% AI-predicted activityagainst MRSA50+ registered studies
- Larotrectinib SulfateExisting use: Abdominal Neoplasms, Cancer, Metastasis and 1 more65.4% AI-predicted activityagainst MRSA5 registered studies
- SirolimusExisting use: Adenoma sebaceum, Angiofibroma, Cancer and 5 more65.2% AI-predicted activityagainst MRSA50+ registered studies
Registered studies
A registration describes a study; it does not establish a positive result.
Exploring PTSD Symptoms, Barriers and Facilitators to Mindfulness
NCT06311188 · start 2026-09-18
Registered record
- Registry ID
- NCT06311188
- Conditions
- Stress; Trauma; PTSD; HPA
- Interventions
- ITR Healing intervention
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Not yet recruiting
- Start
- 2026-09-18
- Completion
- 2027-01-31
- Enrolment
- 90
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionStress; Trauma; PTSD; HPAInterventionITR Healing interventionPhaseNot applicableRegistry statusNot yet recruitingHard and Soft Tissue Outcomes of Vestibular Socket Therapy Using Magnesium Membrane Versus Cortical Lamina in the Esthetic Zone.
NCT07800377 · start 2026-09
Registered record
- Registry ID
- NCT07800377
- Conditions
- Type II Extraction Sockets in the Esthetic Zone
- Interventions
- Vestibular Socket Therapy Using Magnesium Membrane; Vestibular Socket Therapy Using Cortical Lamina
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Not yet recruiting
- Start
- 2026-09
- Completion
- 2027-06
- Enrolment
- 30
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionType II Extraction Sockets in the Esthetic ZoneInterventionVestibular Socket Therapy Using Magnesium Membrane; Vestibular Socket Therapy Using Cortical LaminaPhaseNot applicableRegistry statusNot yet recruitingCortisol and Obesity - A Vicious Cycle? Hypoglycemia After Bariatric Surgery - Association With Cortisol Metabolism?
NCT06896682 · start 2025-07-08
Registered record
- Registry ID
- NCT06896682
- Conditions
- Postbariatric Hypoglycemia
- Interventions
- Not recorded
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Recruiting
- Start
- 2025-07-08
- Completion
- 2026-12-31
- Enrolment
- 100
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionPostbariatric HypoglycemiaInterventionNot recordedPhaseNot recordedRegistry statusRecruitingVirtual Reality to Reduce Intraoperative Anxiety in Vasectomies Under Local Anesthesia
NCT06749353 · start 2025-01
Registered record
- Registry ID
- NCT06749353
- Conditions
- Anxiety
- Interventions
- Virtual reality
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Not yet recruiting
- Start
- 2025-01
- Completion
- 2026-12
- Enrolment
- 148
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionAnxietyInterventionVirtual realityPhaseNot applicableRegistry statusNot yet recruitingVenous Congestion And Delirium After Cardiac Surgery
NCT07285187 · start 2024-11-01
Registered record
- Registry ID
- NCT07285187
- Conditions
- Intraoperative; Venous Congestion; Postoperative Delirium (POD); Cardiac Surgery
- Interventions
- collection of demographic characteristics and comorbidities; surgery-related parameters; POD assessments; collection of biological (laboratory) parameters; collection of hemodynamic parameters; collection of echocardiographic parameters and venous ultrasound assessments; collection of parameters monitoring on the central nervous system
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Recruiting
- Start
- 2024-11-01
- Completion
- 2026-10-31
- Enrolment
- 120
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionIntraoperative; Venous Congestion; Postoperative Delirium (POD); Cardiac SurgeryInterventioncollection of demographic characteristics and comorbidities; surgery-related parameters; POD assessments; collection of biological (laboratory) parameters +3 morePhaseNot recordedRegistry statusRecruitingHair Cortisol as Marker of Chronic Stress in Preterm and Term Fathers - Fathair-study
NCT05969431 · start 2024-10-01
Registered record
- Registry ID
- NCT05969431
- Conditions
- Stress, Psychological; Father-Child Relations; Premature Birth
- Interventions
- measurement of cortisol level
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Recruiting
- Start
- 2024-10-01
- Completion
- 2025-12-31
- Enrolment
- 120
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionStress, Psychological; Father-Child Relations; Premature BirthInterventionmeasurement of cortisol levelPhaseNot recordedRegistry statusRecruitingAthlete Biochemical Monitoring and Nutritional Support
NCT06553963 · start 2024-08-20
Registered record
- Registry ID
- NCT06553963
- Conditions
- Weight Reduction
- Interventions
- Control group; Experimental group
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Unknown
- Start
- 2024-08-20
- Completion
- 2024-09-20
- Enrolment
- 28
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionWeight ReductionInterventionControl group; Experimental groupPhaseNot applicableRegistry statusUnknownEffect of Music on Pain, Anxiety, and Behavior in Anxious Children During Molar Restorations
NCT07144579 · start 2024-08-01
Registered record
- Registry ID
- NCT07144579
- Conditions
- Healhty
- Interventions
- Mozart music group; preferred music group
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2024-08-01
- Completion
- 2025-08-01
- Enrolment
- 45
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionHealhtyInterventionMozart music group; preferred music groupPhaseNot applicableRegistry statusCompletedPsychosocial Effects of Coloring in Preeclamptic Pregnant Women
NCT06925841 · start 2024-03-29
Registered record
- Registry ID
- NCT06925841
- Conditions
- Preeclampsia; Anxiety; Pregnancy; Stress
- Interventions
- Experimental; routine care
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2024-03-29
- Completion
- 2024-12-15
- Enrolment
- 32
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionPreeclampsia; Anxiety; Pregnancy; StressInterventionExperimental; routine carePhaseNot applicableRegistry statusCompletedMotivational Interviewing Inadequate Milk and Cortisol
NCT06344663 · start 2024-03-25
Registered record
- Registry ID
- NCT06344663
- Conditions
- Motivation
- Interventions
- motivational interview
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Unknown
- Start
- 2024-03-25
- Completion
- 2024-12-25
- Enrolment
- 130
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionMotivationInterventionmotivational interviewPhaseNot recordedRegistry statusUnknownStress Reactivity and Hormonal Contraception
NCT06223126 · start 2024-01-22
Registered record
- Registry ID
- NCT06223126
- Conditions
- Hormonal Contraception
- Interventions
- Combined oral contraception; Discontinuation of a combined oral contraception
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Unknown
- Start
- 2024-01-22
- Completion
- 2025-12
- Enrolment
- 75
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionHormonal ContraceptionInterventionCombined oral contraception; Discontinuation of a combined oral contraceptionPhaseNot recordedRegistry statusUnknownStudy of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
NCT06136624 · start 2023-12-31
Registered record
- Registry ID
- NCT06136624
- Conditions
- Prostate Cancer Metastatic
- Interventions
- Opevesostat; Abiraterone acetate; Enzalutamide; Hydrocortisone; Fludrocortisone acetate; Prednisone; Dexamethasone
- Study type
- INTERVENTIONAL
- Phase
- Phase 3
- Registry status
- Recruiting
- Start
- 2023-12-31
- Completion
- 2030-02-15
- Enrolment
- 1,310
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionProstate Cancer MetastaticInterventionOpevesostat; Abiraterone acetate; Enzalutamide; Hydrocortisone +3 morePhasePhase 3Registry statusRecruitingVertical Soft Tissue Augmentation With CTG vs ADM
NCT05729607 · start 2023-05-26
Registered record
- Registry ID
- NCT05729607
- Conditions
- Implant Complication
- Interventions
- Vertical soft tissue augmentation; Vertical soft tissue augmentation
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Recruiting
- Start
- 2023-05-26
- Completion
- 2027-11-27
- Enrolment
- 28
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionImplant ComplicationInterventionVertical soft tissue augmentation; Vertical soft tissue augmentationPhaseNot applicableRegistry statusRecruitingThe Association Between Food Timing and Composition on Gastrointestinal Injury, Stress Hormone and Gastrointestinal Complains.
NCT06403241 · start 2023-05-01
Registered record
- Registry ID
- NCT06403241
- Conditions
- Endothelial Dysfunction
- Interventions
- 2000 meter ergometer test
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Completed
- Start
- 2023-05-01
- Completion
- 2023-06-30
- Enrolment
- 13
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionEndothelial DysfunctionIntervention2000 meter ergometer testPhaseNot recordedRegistry statusCompletedClinical and Metabolic, Immunological and Microbiological Characteristics of Obese Patients
NCT05920785 · start 2023-04-02
Registered record
- Registry ID
- NCT05920785
- Conditions
- Obesity
- Interventions
- Determination of the level of interleukins in the blood, stool analysis for the intestinal microbiome, general clinical tests, glucose tolerance test, hormonal profile
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Active not recruiting
- Start
- 2023-04-02
- Completion
- 2026-04-02
- Enrolment
- 50
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionObesityInterventionDetermination of the level of interleukins in the blood, stool analysis for the intestinal microbiome, general clinical tests, glucose tolerance test, hormonal profilePhaseNot recordedRegistry statusActive not recruiting